Predictors  ||| S:0 E:11 ||| NNP
of  ||| S:11 E:14 ||| IN
ventricular  ||| S:14 E:26 ||| JJ
fibrillation  ||| S:26 E:39 ||| NN
at  ||| S:39 E:42 ||| IN
reperfusion  ||| S:42 E:54 ||| NN
in  ||| S:54 E:57 ||| IN
patients  ||| S:57 E:66 ||| NNS
with  ||| S:66 E:71 ||| IN
acute  ||| S:71 E:77 ||| JJ
ST-elevation  ||| S:77 E:90 ||| JJ
myocardial  ||| S:90 E:101 ||| NNS
infarction  ||| S:101 E:112 ||| VBP
treated  ||| S:112 E:120 ||| VBN
by  ||| S:120 E:123 ||| IN
primary  ||| S:123 E:131 ||| JJ
percutaneous  ||| S:131 E:144 ||| FW
coronary  ||| S:144 E:153 ||| FW
intervention  ||| S:153 E:166 ||| FW
Ventricular  ||| S:166 E:178 ||| FW
fibrillation  ||| S:178 E:191 ||| FW
( ||| S:191 E:192 ||| -LRB-
VF ||| S:192 E:194 ||| NNP
)  ||| S:194 E:196 ||| -RRB-
during  ||| S:196 E:203 ||| IN
reperfusion  ||| S:203 E:215 ||| NNS
( ||| S:215 E:216 ||| -LRB-
rVF ||| S:216 E:219 ||| NNP
)  ||| S:219 E:221 ||| -RRB-
in  ||| S:221 E:224 ||| IN
ST-segment  ||| S:224 E:235 ||| FW
elevation  ||| S:235 E:245 ||| FW
myocardial  ||| S:245 E:256 ||| FW
infarction  ||| S:256 E:267 ||| FW
( ||| S:267 E:268 ||| -LRB-
STEMI ||| S:268 E:273 ||| NNP
)  ||| S:273 E:275 ||| -RRB-
is  ||| S:275 E:278 ||| VBZ
an  ||| S:278 E:281 ||| DT
infrequent  ||| S:281 E:292 ||| JJ
but  ||| S:292 E:296 ||| CC
serious  ||| S:296 E:304 ||| JJ
event  ||| S:304 E:310 ||| NN
that  ||| S:310 E:315 ||| WDT
complicates  ||| S:315 E:327 ||| VBZ
coronary  ||| S:327 E:336 ||| JJ
interventions ||| S:336 E:349 ||| NNS
.  ||| S:349 E:351 ||| .
The  ||| S:351 E:355 ||| DT
aim  ||| S:355 E:359 ||| NN
of  ||| S:359 E:362 ||| IN
this  ||| S:362 E:367 ||| DT
study  ||| S:367 E:373 ||| NN
was  ||| S:373 E:377 ||| VBD
to  ||| S:377 E:380 ||| TO
analyze  ||| S:380 E:388 ||| VB
clinical  ||| S:388 E:397 ||| JJ
predictors  ||| S:397 E:408 ||| NN
of  ||| S:408 E:411 ||| IN
rVF  ||| S:411 E:415 ||| JJ
in  ||| S:415 E:418 ||| IN
an  ||| S:418 E:421 ||| DT
unselected  ||| S:421 E:432 ||| JJ
population  ||| S:432 E:443 ||| NN
of  ||| S:443 E:446 ||| IN
patients  ||| S:446 E:455 ||| NNS
with  ||| S:455 E:460 ||| IN
STEMI  ||| S:460 E:466 ||| NNP
treated  ||| S:466 E:474 ||| VBD
with  ||| S:474 E:479 ||| IN
percutaneous  ||| S:479 E:492 ||| JJ
coronary  ||| S:492 E:501 ||| JJ
intervention  ||| S:501 E:514 ||| NN
( ||| S:514 E:515 ||| -LRB-
PCI ||| S:515 E:518 ||| NNP
) ||| S:518 E:519 ||| -RRB-
.  ||| S:519 E:521 ||| .
Consecutive  ||| S:521 E:533 ||| JJ
patients  ||| S:533 E:542 ||| NNS
with  ||| S:542 E:547 ||| IN
STEMI  ||| S:547 E:553 ||| NNP
admitted  ||| S:553 E:562 ||| VBD
to  ||| S:562 E:565 ||| TO
a  ||| S:565 E:567 ||| DT
tertiary  ||| S:567 E:576 ||| JJ
care  ||| S:576 E:581 ||| NN
hospital  ||| S:581 E:590 ||| NN
for  ||| S:590 E:594 ||| IN
primary  ||| S:594 E:602 ||| JJ
PCI  ||| S:602 E:606 ||| NN
from  ||| S:606 E:611 ||| IN
2007  ||| S:611 E:616 ||| CD
to  ||| S:616 E:619 ||| TO
2012  ||| S:619 E:624 ||| CD
were  ||| S:624 E:629 ||| VBD
retrospectively  ||| S:629 E:645 ||| VBN
assessed  ||| S:645 E:654 ||| VBN
for  ||| S:654 E:658 ||| IN
the  ||| S:658 E:662 ||| DT
presence  ||| S:662 E:671 ||| NN
of  ||| S:671 E:674 ||| IN
rVF ||| S:674 E:677 ||| JJ
.  ||| S:677 E:679 ||| .
Admission  ||| S:679 E:689 ||| NN
electrocardiograms ||| S:689 E:707 ||| NN
,  ||| S:707 E:709 ||| ,
stored  ||| S:709 E:716 ||| VBD
in  ||| S:716 E:719 ||| IN
a  ||| S:719 E:721 ||| DT
digital  ||| S:721 E:729 ||| JJ
format ||| S:729 E:735 ||| NN
,  ||| S:735 E:737 ||| ,
were  ||| S:737 E:742 ||| VBD
analyzed  ||| S:742 E:751 ||| VBN
for  ||| S:751 E:755 ||| IN
a  ||| S:755 E:757 ||| DT
maximal  ||| S:757 E:765 ||| JJ
ST-segment  ||| S:765 E:776 ||| JJ
elevation  ||| S:776 E:786 ||| NN
in  ||| S:786 E:789 ||| IN
a  ||| S:789 E:791 ||| DT
single  ||| S:791 E:798 ||| JJ
lead  ||| S:798 E:803 ||| NN
and  ||| S:803 E:807 ||| CC
the  ||| S:807 E:811 ||| DT
sum  ||| S:811 E:815 ||| NN
of  ||| S:815 E:818 ||| IN
ST-segment  ||| S:818 E:829 ||| JJ
deviations  ||| S:829 E:840 ||| NNS
in  ||| S:840 E:843 ||| IN
all  ||| S:843 E:847 ||| DT
leads ||| S:847 E:852 ||| NNS
.  ||| S:852 E:854 ||| .
Clinical ||| S:854 E:862 ||| NNP
,  ||| S:862 E:864 ||| ,
electrocardiographic ||| S:864 E:884 ||| NN
,  ||| S:884 E:886 ||| ,
and  ||| S:886 E:890 ||| CC
angiographic  ||| S:890 E:903 ||| JJ
characteristics  ||| S:903 E:919 ||| NNS
were  ||| S:919 E:924 ||| VBD
tested  ||| S:924 E:931 ||| VBN
for  ||| S:931 E:935 ||| IN
associations  ||| S:935 E:948 ||| NNS
with  ||| S:948 E:953 ||| IN
rVF  ||| S:953 E:957 ||| JJ
using  ||| S:957 E:963 ||| VBG
logistic  ||| S:963 E:972 ||| JJ
regression  ||| S:972 E:983 ||| JJ
analysis ||| S:983 E:991 ||| NN
.  ||| S:991 E:993 ||| .
Among  ||| S:993 E:999 ||| IN
3,724  ||| S:999 E:1005 ||| CD
patients  ||| S:1005 E:1014 ||| NNS
with  ||| S:1014 E:1019 ||| IN
STEMI  ||| S:1019 E:1025 ||| NNP
admitted  ||| S:1025 E:1034 ||| VBD
from  ||| S:1034 E:1039 ||| IN
2007  ||| S:1039 E:1044 ||| CD
to  ||| S:1044 E:1047 ||| TO
2012 ||| S:1047 E:1051 ||| CD
,  ||| S:1051 E:1053 ||| ,
71  ||| S:1053 E:1056 ||| CD
( ||| S:1056 E:1057 ||| -LRB-
1.9 ||| S:1057 E:1060 ||| CD
% ||| S:1060 E:1061 ||| NN
)  ||| S:1061 E:1063 ||| -RRB-
had  ||| S:1063 E:1067 ||| VBD
rVF ||| S:1067 E:1070 ||| JJ
.  ||| S:1070 E:1072 ||| .
In  ||| S:1072 E:1075 ||| IN
univariate  ||| S:1075 E:1086 ||| JJ
analysis ||| S:1086 E:1094 ||| NN
,  ||| S:1094 E:1096 ||| ,
history  ||| S:1096 E:1104 ||| NN
of  ||| S:1104 E:1107 ||| IN
myocardial  ||| S:1107 E:1118 ||| JJ
infarction ||| S:1118 E:1128 ||| NN
,  ||| S:1128 E:1130 ||| ,
aspirin  ||| S:1130 E:1138 ||| NN
and  ||| S:1138 E:1142 ||| CC
β-blocker  ||| S:1142 E:1152 ||| JJ
use ||| S:1152 E:1155 ||| NN
,  ||| S:1155 E:1157 ||| ,
VF  ||| S:1157 E:1160 ||| NNP
before  ||| S:1160 E:1167 ||| IN
PCI ||| S:1167 E:1170 ||| NNP
,  ||| S:1170 E:1172 ||| ,
left  ||| S:1172 E:1177 ||| VBD
main  ||| S:1177 E:1182 ||| JJ
coronary  ||| S:1182 E:1191 ||| JJ
artery  ||| S:1191 E:1198 ||| NN
disease ||| S:1198 E:1205 ||| NN
,  ||| S:1205 E:1207 ||| ,
inferior  ||| S:1207 E:1216 ||| FW
myocardial  ||| S:1216 E:1227 ||| FW
infarction  ||| S:1227 E:1238 ||| FW
localization ||| S:1238 E:1250 ||| FW
,  ||| S:1250 E:1252 ||| ,
symptom-to-balloon  ||| S:1252 E:1271 ||| JJ
time  ||| S:1271 E:1276 ||| NN
< ||| S:1276 E:1277 ||| SYM
360  ||| S:1277 E:1281 ||| CD
minutes ||| S:1281 E:1288 ||| NNS
,  ||| S:1288 E:1290 ||| ,
maximal  ||| S:1290 E:1298 ||| JJ
ST-segment  ||| S:1298 E:1309 ||| JJ
elevation  ||| S:1309 E:1319 ||| NN
in  ||| S:1319 E:1322 ||| IN
a  ||| S:1322 E:1324 ||| DT
single  ||| S:1324 E:1331 ||| JJ
lead  ||| S:1331 E:1336 ||| NN
> ||| S:1336 E:1337 ||| CD
300  ||| S:1337 E:1341 ||| CD
μV ||| S:1341 E:1343 ||| NN
,  ||| S:1343 E:1345 ||| ,
and  ||| S:1345 E:1349 ||| CC
sum  ||| S:1349 E:1353 ||| NN
of  ||| S:1353 E:1356 ||| IN
ST-segment  ||| S:1356 E:1367 ||| JJ
deviations  ||| S:1367 E:1378 ||| NNS
in  ||| S:1378 E:1381 ||| IN
all  ||| S:1381 E:1385 ||| DT
leads  ||| S:1385 E:1391 ||| VBZ
> ||| S:1391 E:1392 ||| CD
1,500  ||| S:1392 E:1398 ||| CD
μV  ||| S:1398 E:1401 ||| NN
were  ||| S:1401 E:1406 ||| VBD
associated  ||| S:1406 E:1417 ||| VBN
with  ||| S:1417 E:1422 ||| IN
increased  ||| S:1422 E:1432 ||| JJ
risk  ||| S:1432 E:1437 ||| NN
for  ||| S:1437 E:1441 ||| IN
rVF ||| S:1441 E:1444 ||| JJ
.  ||| S:1444 E:1446 ||| .
In  ||| S:1446 E:1449 ||| IN
a  ||| S:1449 E:1451 ||| DT
multivariate  ||| S:1451 E:1464 ||| JJ
analysis ||| S:1464 E:1472 ||| NN
,  ||| S:1472 E:1474 ||| ,
sum  ||| S:1474 E:1478 ||| NN
of  ||| S:1478 E:1481 ||| IN
ST-segment  ||| S:1481 E:1492 ||| JJ
deviations  ||| S:1492 E:1503 ||| NNS
in  ||| S:1503 E:1506 ||| IN
all  ||| S:1506 E:1510 ||| DT
leads  ||| S:1510 E:1516 ||| VBZ
> ||| S:1516 E:1517 ||| CD
1500  ||| S:1517 E:1522 ||| CD
μV  ||| S:1522 E:1525 ||| NNS
( ||| S:1525 E:1526 ||| -LRB-
odds  ||| S:1526 E:1531 ||| JJ
ratio  ||| S:1531 E:1537 ||| NN
3.7 ||| S:1537 E:1540 ||| CD
,  ||| S:1540 E:1542 ||| ,
95 ||| S:1542 E:1544 ||| CD
%  ||| S:1544 E:1546 ||| NN
confidence  ||| S:1546 E:1557 ||| NN
interval  ||| S:1557 E:1566 ||| VBD
1.45  ||| S:1566 E:1571 ||| CD
to  ||| S:1571 E:1574 ||| TO
9.41 ||| S:1574 E:1578 ||| CD
,  ||| S:1578 E:1580 ||| ,
p  ||| S:1580 E:1582 ||| VBG
=  ||| S:1582 E:1584 ||| SYM
0.006 ||| S:1584 E:1589 ||| CD
)  ||| S:1589 E:1591 ||| -RRB-
before  ||| S:1591 E:1598 ||| IN
PCI  ||| S:1598 E:1602 ||| NNP
remained  ||| S:1602 E:1611 ||| VBD
an  ||| S:1611 E:1614 ||| DT
independent  ||| S:1614 E:1626 ||| JJ
predictor  ||| S:1626 E:1636 ||| NN
of  ||| S:1636 E:1639 ||| IN
rVF ||| S:1639 E:1642 ||| JJ
.  ||| S:1642 E:1644 ||| .
In-hospital  ||| S:1644 E:1656 ||| JJ
mortality  ||| S:1656 E:1666 ||| NN
was  ||| S:1666 E:1670 ||| VBD
18.3 ||| S:1670 E:1674 ||| CD
%  ||| S:1674 E:1676 ||| NN
in  ||| S:1676 E:1679 ||| IN
the  ||| S:1679 E:1683 ||| DT
rVF  ||| S:1683 E:1687 ||| JJ
group  ||| S:1687 E:1693 ||| NN
and  ||| S:1693 E:1697 ||| CC
3.3 ||| S:1697 E:1700 ||| CD
%  ||| S:1700 E:1702 ||| NN
in  ||| S:1702 E:1705 ||| IN
the  ||| S:1705 E:1709 ||| DT
group  ||| S:1709 E:1715 ||| NN
without  ||| S:1715 E:1723 ||| IN
VF  ||| S:1723 E:1726 ||| NNP
( ||| S:1726 E:1727 ||| -LRB-
p  ||| S:1727 E:1729 ||| FW
< ||| S:1729 E:1730 ||| SYM
0.001 ||| S:1730 E:1735 ||| FW
) ||| S:1735 E:1736 ||| -RRB-
,  ||| S:1736 E:1738 ||| ,
but  ||| S:1738 E:1742 ||| CC
rVF  ||| S:1742 E:1746 ||| NNP
was  ||| S:1746 E:1750 ||| VBD
not  ||| S:1750 E:1754 ||| RB
an  ||| S:1754 E:1757 ||| DT
independent  ||| S:1757 E:1769 ||| JJ
predictor  ||| S:1769 E:1779 ||| NN
of  ||| S:1779 E:1782 ||| IN
in-hospital  ||| S:1782 E:1794 ||| JJ
death ||| S:1794 E:1799 ||| NN
.  ||| S:1799 E:1801 ||| .
In  ||| S:1801 E:1804 ||| IN
conclusion ||| S:1804 E:1814 ||| NN
,  ||| S:1814 E:1816 ||| ,
the  ||| S:1816 E:1820 ||| DT
magnitude  ||| S:1820 E:1830 ||| NN
of  ||| S:1830 E:1833 ||| IN
ST-segment  ||| S:1833 E:1844 ||| JJ
elevation  ||| S:1844 E:1854 ||| NN
before  ||| S:1854 E:1861 ||| IN
PCI  ||| S:1861 E:1865 ||| NNP
for  ||| S:1865 E:1869 ||| IN
STEMI  ||| S:1869 E:1875 ||| NNP
independently  ||| S:1875 E:1889 ||| RB
predicts  ||| S:1889 E:1898 ||| VBZ
rVF  ||| S:1898 E:1902 ||| JJ
and  ||| S:1902 E:1906 ||| CC
should  ||| S:1906 E:1913 ||| MD
be  ||| S:1913 E:1916 ||| VB
considered  ||| S:1916 E:1927 ||| VBN
in  ||| S:1927 E:1930 ||| IN
periprocedural  ||| S:1930 E:1945 ||| JJ
arrhythmic  ||| S:1945 E:1956 ||| JJ
risk  ||| S:1956 E:1961 ||| NN
assessment ||| S:1961 E:1971 ||| NN
.  ||| S:1971 E:1973 ||| .
Despite  ||| S:1973 E:1981 ||| IN
higher  ||| S:1981 E:1988 ||| JJR
in-hospital  ||| S:1988 E:2000 ||| JJ
mortality  ||| S:2000 E:2010 ||| NN
in  ||| S:2010 E:2013 ||| IN
patients  ||| S:2013 E:2022 ||| NNS
with  ||| S:2022 E:2027 ||| IN
rVF ||| S:2027 E:2030 ||| NNP
,  ||| S:2030 E:2032 ||| ,
rVF  ||| S:2032 E:2036 ||| JJ
itself  ||| S:2036 E:2043 ||| PRP
has  ||| S:2043 E:2047 ||| VBZ
no  ||| S:2047 E:2050 ||| DT
independent  ||| S:2050 E:2062 ||| JJ
prognostic  ||| S:2062 E:2073 ||| JJ
value  ||| S:2073 E:2079 ||| NN
for  ||| S:2079 E:2083 ||| IN
prognosis ||| S:2083 E:2092 ||| NN
.  ||| S:2092 E:2094 ||| .
